Consensus $139.39M. Narrows FY25 adjusted EBITDA view to up 22%-23% from up 22%-24%. “Our business has performed well during the first nine months of the year and we believe that our results reflect the healthy demand for innovative HCM products from business owners of all sizes. Our efforts on product integration and increasing attach rates in our business continue to make great strides. As we look forward to the remainder of 2025 and into next year, we believe that we are positioned well for continued growth and improving profitability going forward.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASUR:
